Height, weight, and motor-social development of children exposed to metformin in utero because their mothers with polycystic ovary syndrome or Gestational Diabetes

Height, weight, and motor-social development of children exposed to metformin in utero because their mother with polycystic ovary syndrome or Gestational Diabetes

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-12002652

Enrollment

Unknown

Registered

2012-11-04

Start date

2007-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes,polycystic ovary syndrome,

Interventions

metformin group:taken metformin during pregnancy

Eligibility

Sex/Gender

Female

Age

23 Years to 43 Years

Inclusion criteria

Inclusion criteria: the patients who were taken metformin during pregnany because of polycystic ovary syndrome or Gestational Diabetes.

Exclusion criteria

Exclusion criteria: Pregnancy with thyroid disease; patients who were suffer from hypertension, diabetes mellitus or genetic disorder hereditary disease.

Design outcomes

Primary

Measure	Time frame
The incidence of adverse complications;height of children;weight of children;	—

Countries

China

Contacts

Public ContactYun-Hui Wang

why48100@163.com+86 13926002933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026